A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
| Image |  |
|---|---|
| Description | scientific article published on February 23, 2013 |
| Author/s |
author: David Fiorentino Brandon W. Higgs |
| Publication date | February 23, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |